Focus Partners Wealth’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Focus Partners Wealth's HALO Position: Q2 2026 in Review
Focus Partners Wealth reduced its Halozyme (HALO) stake by 3.7% in Q2 2026, selling an estimated $426K and leaving 163,036 shares worth $12.8M. The position accounts for 0.01% of the portfolio, ranked #636.
Focus Partners Wealth first reported a position in HALO in Q4 2023 and has held it in 11 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Focus Partners Wealth held 163,036 shares of Halozyme worth $12.8M as of Q2 2026.
- Focus Partners Wealth sold 6,250 Halozyme shares in Q2 2026, an estimated $426K.
- Halozyme made up 0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #636 holding.
- Focus Partners Wealth first reported a position in Halozyme in Q4 2023 and has held it in 11 quarters since.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.